Clinical • Journal • Gene Signature
|
KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • CD8 (cluster of differentiation 8) • EREG (Epiregulin) • ITGA5 (Integrin Subunit Alpha 5)
|
TP53 mutation • CDKN2A mutation
|
dasatinib • gemcitabine • BMS-536924